HC Wainwright & Co. Reiterates Buy on Adagene, Maintains $7 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 90.8%

Neg 0% Neu 90.8% Pos 0%

HC Wainwright & Co. analyst Arthur He reiterates Adagene (NASDAQ:ADAG) with a Buy and maintains $7 price target.

Comments

No comments yet. Be the first!